phosphorylcholine has been researched along with Candidiasis in 6 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study is to evaluate the effects of 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer coating with various concentrations onto acrylic resin denture base material on surface characteristics such as contact angle and surface roughness and on Candida albicans adhesion which is the major factor of denture stomatitis." | 3.88 | Examination of 2-methacryloyloxyethyl phosphorylcholine polymer coated acrylic resin denture base material: surface characteristics and Candida albicans adhesion. ( Akca, G; Bat, E; Nalbant, AD; Türkcan, İ, 2018) |
| "Miltefosine is an alkylphosphocholine that shows broad-spectrum in vitro antifungal activities and limited in vivo efficacy in mouse models of cryptococcosis." | 3.79 | Synthesis and antifungal activities of miltefosine analogs. ( Agarwal, AK; Chen, YL; Clark, AM; Heitman, J; Jacob, MR; Khan, SI; Li, XC; Pan, X; Ravu, RR, 2013) |
| "Treatment with miltefosine at 1000 μg ml- 1 inhibited biofilm formation by 89% and reduced the metabolic activity of pre-formed C." | 1.42 | Miltefosine is effective against Candida albicans and Fusarium oxysporum nail biofilms in vitro. ( Machado Vila, TV; Rozental, S; Sousa Quintanilha, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Y | 1 |
| Totten, M | 1 |
| Memon, W | 1 |
| Ying, C | 1 |
| Zhang, SX | 1 |
| Türkcan, İ | 1 |
| Nalbant, AD | 1 |
| Bat, E | 1 |
| Akca, G | 1 |
| Spadari, CC | 1 |
| de Bastiani, FWMDS | 1 |
| Lopes, LB | 1 |
| Ishida, K | 2 |
| Ravu, RR | 1 |
| Chen, YL | 1 |
| Jacob, MR | 1 |
| Pan, X | 1 |
| Agarwal, AK | 1 |
| Khan, SI | 1 |
| Heitman, J | 1 |
| Clark, AM | 1 |
| Li, XC | 1 |
| Machado Vila, TV | 1 |
| Sousa Quintanilha, N | 1 |
| Rozental, S | 2 |
| Vila, T | 1 |
| Seabra, SH | 1 |
6 other studies available for phosphorylcholine and Candidiasis
| Article | Year |
|---|---|
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple; Drug Therapy, Co | 2020 |
Examination of 2-methacryloyloxyethyl phosphorylcholine polymer coated acrylic resin denture base material: surface characteristics and Candida albicans adhesion.
Topics: Acrylic Resins; Biofilms; Candida albicans; Candidiasis; Coated Materials, Biocompatible; Denture Ba | 2018 |
Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis.
Topics: Alginates; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Drug Delivery | 2019 |
Synthesis and antifungal activities of miltefosine analogs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cell Line; C | 2013 |
Miltefosine is effective against Candida albicans and Fusarium oxysporum nail biofilms in vitro.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fusariosis; Fusarium; Humans; Nail Disea | 2015 |
Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells.
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Female; Humans; Inhibitory Concentration 50; Male | 2016 |